Meeting
2018 ASCO Annual Meeting
PBRM1 mutation and immunotherapy efficacy: A comprehensive genomic profiling (CGP) assessment.
Authors
Gennady Bratslavsky
SUNY Upstate Medical University, Syracuse, NY
Gennady Bratslavsky , Laurie M. Gay , Ethan Sokol , Julia Andrea Elvin , Jo-Anne Vergilio , James Suh , Shakti H. Ramkissoon , Sugganth Daniel , Eric Allan Severson , Jonathan Keith Killian , Siraj Mahamed Ali , Jon Chung , Alexa Betzig Schrock , Garrett Michael Frampton , David Fabrizio , Vincent A. Miller , Muhammad Raza Naqvi , Mehdi Mollapour , Robert John Corona , Jeffrey S. Ross
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Tumor-Based Biomarkers
Citation
J Clin Oncol 36, 2018 (suppl; abstr 12091)
DOI
10.1200/JCO.2018.36.15_suppl.12091
Abstract #
12091
Poster Bd #
204
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Comprehensive genomic profiling (CGP) of chromophobe renal cell carcinoma (chrRCC) compared with non-chromophobe RCC (nonchrRCC): Impact of FLCN genomic alteration (GA) status.
First Author: Gennady Bratslavsky
Poster
2020 ASCO Virtual Scientific Program
Comprehensive genomic profiling of 216 Chinese patients with renal cell carcinoma.
First Author: Congwang Zhang
Poster
2018 ASCO Annual Meeting
FGFR3 Driven Metastatic Urothelial Carcinoma of the Urinary Bladder (mUCB): A Comprehensive Genomic Profiling Study.
First Author: Jeffrey S. Ross
Poster
2016 Genitourinary Cancers Symposium
Assessing the frequency of somatic mutations in high-risk clear cell renal cell carcinoma to provide new perspectives.
First Author: Brandon Manley